 Risk factors reactions borderline leprosy patients reactions major cause nerve damage disability leprosy clinical laboratory markers patients risk reaction Nepalese borderline leprosy patients male female age range years reaction first years multi-drug therapy therapy patients seropositive antibodies mycobacterial antigens Seropositivity IgM antibodies IgG anti-lipoarabinomannan anti-Mycobacterium leprae kDa protein antibodies subsequent manifestation reaction concentration IgM antibodies serum patients reaction risk attributable seropositivity independent leprosy class smear positivity presence anti-M leprae antibodies odds patients lepromin test seropositivity lepromin reactivity significant independent risk factors subsequent reaction patients positive lepromin reactivity IgM antibodies reactions Patients risk factors antimicrobial therapy early initiation anti-inflammatory treatment permanent nerve damage resultant disability